🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Left Atrial Posterior Wall and Mitral Isthmus PF Ablation in Non-Paroxysmal AF Patients

Recruitingn/aAges 18 Years - anyAllCharles University, Czech Republic
NCT06801392 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

An observational study evaluating efficacy and safety of the Varipulse catheter in pulsed-field ablation of atrial fibrillation

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. non-paroxysmal atrial fibrillation 2. an indication for catheter ablation according current guidelines 3. willingness to sign informed content. Exclusion Criteria: 1. hematological disorders that can be associated with spontaneous hemolysis 2. chronic kidney disease stage 3 or worse 3. previous left atrial ablation (either using pulsed-field or radiofrequency energy)
💊

What it tests

  • pulsed-field ablation
📍

Where

1 site
University Hospital Kralovske Vinohrady
Prague, Czechia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy